Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2012
10/26/2012CA2832874A1 Novel modulators of cortical dopaminergic- and nmda-receptor-mediated glutamatergic neurotransmission
10/26/2012CA2832866A1 Acadesine derivatives, products and compositions including same, therapeutic uses thereof, and methods for synthesizing same
10/26/2012CA2832865A1 Aminopyrimidine kinase inhibitors
10/26/2012CA2832860A1 Therapy for leukemia
10/26/2012CA2832854A1 Method of inhibiting harmful microorganisms and barrier-forming composition therefor
10/26/2012CA2832763A1 Tetrahydroquinoline derivatives useful as bromodomain inhibitors
10/26/2012CA2832507A1 Nutritional compositions having alpha-hica and eicosapentaenoic acid
10/26/2012CA2832343A1 Multicomponent crystalline system of rosuvastatin calcium salt and vanillin
10/26/2012CA2832150A1 Nutritional compositions having alpha-hica and alpha-ketoglutarate
10/26/2012CA2832145A1 Method for purification of micafungin
10/26/2012CA2831869A1 Method for modulating cytokine activity
10/26/2012CA2831830A1 2-oxo-1-imidazolidinyl imidazothiadiazole derivatives
10/26/2012CA2831730A1 A crystalline form of a salt of a morpholino sulfonyl indole derivative and a process for its preparation
10/26/2012CA2831680A1 Heterocyclic compounds as kinase inhibitors
10/26/2012CA2831650A1 Medical products for use in conditions related to microbial infections in the upper aerodigestive tract
10/26/2012CA2831634A1 Pyrazolo [4,3-d] pyrimidines useful as kinase inhibitors
10/26/2012CA2831380A1 Pyrazolospiroketone derivatives for use as acetyl-coa carboxylase inhibitors
10/26/2012CA2831338A1 Androgen receptor modulating carboxamides
10/26/2012CA2831165A1 Nutritional compositions having .alpha.-hica and citrulline and methods of using same
10/26/2012CA2831001A1 Nutritional compositions comprising alpha-hydroxyisocaproic acid
10/26/2012CA2828946A1 Therapeutic agent for tumor
10/26/2012CA2825971A1 5-(phenyl/pyridinyl-ethinyl) -2 -pyridine/ 2 -pyrimidine-carborxamides as mglur5 modulators
10/26/2012CA2824757A1 Phenyl-isoxazol derivatives and preparation process thereof
10/25/2012US20120272346 Identification of rnai targets and use of rnai for rational therapy of chemotherapy-resistant leukemia and other cancers
10/25/2012US20120271275 Medical devices and methods comprising an anabolic agent for wound healing
10/25/2012US20120271056 Process for the preparation of crystalline form i of l-malic acid salt of sunitinib
10/25/2012US20120270954 Methods for maintaining eye health and ameliorating opthalmic maladies in canines
10/25/2012US20120270953 Methods and compositions for the treatment of infection or infectious colonization of the eyelid, ocular surface, skin or ear
10/25/2012US20120270952 Method for enhancing the bioavailability of ospemifene
10/25/2012US20120270951 Novel anti-inflammatory cyclooxygenase inhibitors
10/25/2012US20120270950 Alkaline decomposition product of hop extract and use thereof
10/25/2012US20120270949 Melt-granulated cinacalcet
10/25/2012US20120270948 Polymorphisims in the human cyp2d6 gene promoter region and their use in diagnostic and therapeutic applications
10/25/2012US20120270947 Short Telomere Length on Chromosome 9P is Strongly Associated with Breast Cancer Risk
10/25/2012US20120270946 Crystalline form of bimatoprost, preparation method and use thereof
10/25/2012US20120270945 Method for modulating cytokine activity
10/25/2012US20120270943 D-aspartic Acid Pro-nutrients with Improved Solubility Characteristics
10/25/2012US20120270941 Topical application of travoprost for combating hair loss
10/25/2012US20120270940 Closthioamides
10/25/2012US20120270939 Formulations and methods for treating amyloidosis
10/25/2012US20120270938 Small molecules that covalently modify transthyretin
10/25/2012US20120270937 Linear self-eliminating oligomers
10/25/2012US20120270936 Composition and method for treatment of inflamation and infections of the genitalia, contraceptive and the prophylaxis of sexually transmitted diseases
10/25/2012US20120270935 Formulations
10/25/2012US20120270934 Prostacyclin derivatives
10/25/2012US20120270933 Liquid statin formulation
10/25/2012US20120270932 Personal Care Compositions with Improved Hyposensitivity
10/25/2012US20120270931 Stable pharmaceutical formulations comprising lubiprostone
10/25/2012US20120270930 Methods and compositions for dysferlin exon-skipping
10/25/2012US20120270929 Modulation of ttc39 expression to increase hdl
10/25/2012US20120270928 Microrna compounds and methods for modulating mir-21 activity
10/25/2012US20120270927 Polyamides For Nucleic Acid Delivery
10/25/2012US20120270925 Antisense molecules and methods for treating pathologies
10/25/2012US20120270924 Oligomeric Compounds For The Modultion of HIF-1A Expression
10/25/2012US20120270923 Natriuretic peptide receptor as a biomarker for diagnosis and prognosis of cancer
10/25/2012US20120270922 Antiangiogenic Agent and Method for Inhibition of Angiogenesis
10/25/2012US20120270921 Lipid Formulated Compositions and Methods for Inhibiting Expression of a Gene from the Ebola Virus
10/25/2012US20120270920 Compositions and methods for treatment of pouchitis
10/25/2012US20120270919 Proteasome inhibitors
10/25/2012US20120270918 Pyrazole Derivatives, Preparation Thereof, and Therapeutic Use Thereof
10/25/2012US20120270917 Adamantane analogs
10/25/2012US20120270916 Topical formulations for treating neuropathy
10/25/2012US20120270915 Fatty acid amide hydrolase inhihibitors for treating pain
10/25/2012US20120270914 Split-luciferase c-myc sensor and uses thereof
10/25/2012US20120270912 Substituted Indolealkanoic Acids
10/25/2012US20120270911 Novel salts and polymorphs of desazadesferrithiocin polyether analogues as metal chelation agents
10/25/2012US20120270910 Pharmaceutical containing ppar-delta agonist
10/25/2012US20120270909 Method of inhibiting harmful microorganisms and barrier-forming composition therefor
10/25/2012US20120270908 Substituted 3 -hydrozypyridines and pharmaceutical compositions thereof
10/25/2012US20120270907 Therapeutic uses of nicotine
10/25/2012US20120270906 Cyclohexane derivative and pharmaceutical use thereof
10/25/2012US20120270905 Fluorinated 2,6-dialkyl-3,5-dicyano-4-(1h-indazol-5-yl)-1,4-dihydropyridines and methods of use thereof
10/25/2012US20120270903 Intranasal spray device containing pharmaceutical composition
10/25/2012US20120270902 N-substituted benzene sulfonamides
10/25/2012US20120270901 Indene derivatives as pharmaceutical agents
10/25/2012US20120270900 Novel method of treatment
10/25/2012US20120270899 Compositions and Methods for Treating Cardiovascular Diseases
10/25/2012US20120270898 Sulfonamide compound and crystal thereof
10/25/2012US20120270897 Acetylene derivatives of 5-phenyl-pyrazolopyridine, preparation thereof, and therapeutic use thereof
10/25/2012US20120270896 Antineoplastic Combinations Containing HKI-272 and Vinorelbine
10/25/2012US20120270895 Intranasal Opioid Compositions
10/25/2012US20120270894 Controlled Release of Phenolic Opioids
10/25/2012US20120270893 Substituted acetyl-coa carboxylase inhibitors
10/25/2012US20120270892 Aminopyrimidine Kinase Inhibitors
10/25/2012US20120270891 Salts of 4-Methyl-N-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-phenyl]-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-benzamide
10/25/2012US20120270890 Methods of Pancreatic Beta Cell Regeneration
10/25/2012US20120270889 Compound, certain novel forms thereof, pharmaceutical compositions thereof and methods for preparation and use
10/25/2012US20120270888 Pharmaceutical compositions of raltegravir, methods of preparation and use thereof
10/25/2012US20120270887 Method Of Inhibiting Myopia And Application Of An Adenylyl Cyclase Inhibitor As A Drug For inhibiting Myopia
10/25/2012US20120270886 Inhibitors of iap
10/25/2012US20120270884 Methods of Treating Aneurysmal Dilatation, Blood Vessel Wall Weakness and Specifically Abdominal Aortic and Thoracic Aneurysm Using Matrix Metalloprotease-2 Inhibitors
10/25/2012US20120270883 Use of a polymorph of flibanserin for treating disease
10/25/2012US20120270882 Fluorinated derivates of 3-hydroxypyridin-4-ones
10/25/2012US20120270881 Conformationally constrained, fully synthetic macrocyclic compounds
10/25/2012US20120270880 Pyrrolo [2,3-d] pyrazin-7-ylpyrimidine compounds
10/25/2012US20120270879 Heterocyclic Compounds As CCR1 Receptor Antagonists
10/25/2012US20120270878 Inhibition of p38 kinase using symmetrical and unsymmetrical diphenyl ureas
10/25/2012US20120270877 IRE-1alpha INHIBITORS
10/25/2012US20120270876 Treatment of Conditions Through Pharmacological Modulation of the Autonomic Nervous System
10/25/2012US20120270875 Pyrimidine amide compounds
1 ... 984 985 986 987 988 989 990 991 992 993 994 995 996 997 998 999 1000 1001 1002 1003 1004 ... 7860